Podchaser Logo
Home
Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond | S4E3

Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond | S4E3

Released Tuesday, 25th June 2024
Good episode? Give it some love!
Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond | S4E3

Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond | S4E3

Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond | S4E3

Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond | S4E3

Tuesday, 25th June 2024
Good episode? Give it some love!
Rate Episode

Dr. Solange Peters shares invaluable insights into the management of ALK-positive NSCLC with a special focus on adjuvant therapy.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features